Dianthus Therapeutics, Inc. /DE/ - 10-Q Filing
Dianthus Therapeutics reports Q3 2026 financial results featuring milestone payments from Iontas Limited and ongoing R&D activities.
Tickers: $DNTH
Dianthus Therapeutics reports Q3 2026 financial results featuring milestone payments from Iontas Limited and ongoing R&D activities.
Tickers: $DNTH